Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-2 antiplasmin (α2AP), also known as plasmin inhibitor, is a key serine protease inhibitor (serpin) that plays a central role in regulating fibrinolysis by inactivating plasmin, the primary enzyme responsible for breaking down blood clots. It is primarily synthesized by hepatocytes in the liver and released into circulation.
Inhibits plasmin by forming a stable complex, preventing fibrin clot breakdown.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-2 antiplasmin (α2AP).